11
Myers
AstraZeneca Plunges: Investors Revolt Against Bristol Myers Tie-Up
AstraZeneca Shares Tumble on Reported $400 Billion Merger Talks with Bristol Myers Squibb Quick Take: AstraZeneca’s stock fell sharply after…